Furthermore, the c-Fos expression in anxiety- and fear-related brain regions, including BNST22 and BLA23 showed no significant difference between sevoflurane-treated mice and control, which is also consistent with the EPM results (Fig. 2b). The gene discussed is FOS; the disease is Anxiety.